Accelerate Diagnostics (AXDX) Expected to Announce Quarterly Earnings on Thursday

Accelerate Diagnostics (NASDAQ:AXDX) is anticipated to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.46) per share and revenue of $3.00 million for the quarter.

Accelerate Diagnostics Stock Performance

Shares of AXDX stock opened at $1.12 on Thursday. The firm’s 50 day moving average price is $1.17 and its 200-day moving average price is $1.46. Accelerate Diagnostics has a one year low of $0.73 and a one year high of $2.09. The firm has a market cap of $27.92 million, a P/E ratio of -0.39 and a beta of 0.55.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. StockNews.com assumed coverage on shares of Accelerate Diagnostics in a report on Monday. They issued a “hold” rating on the stock. BTIG Research upgraded shares of Accelerate Diagnostics to a “strong-buy” rating in a report on Wednesday, December 11th.

About Accelerate Diagnostics

Accelerate Diagnostics, Inc, an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.